497件中 497件の動画が該当しました。
表示方法 画像とタイトル 詳細表示
thm_02-4

日独におけるSGLT2阻害剤の位置づけ

視聴時間
0 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 5

糖尿病治療の国内外のエキスパートの先生方に、SGLT2阻害剤の魅力と、長期にわたる血糖低下効果が認められたフォシーガの臨床的価値について語っていただきました。


島野 仁 先生 / Stephan Jacob 先生

NEW
Madison Clinic for Pediatric Diabetes, University of California San Francisco

Madison Clinic for P・・・

視聴時間5:10
0 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 5

Our aim is to ease the burden of diabetes and improve the lives of our patients and their families through compassionate and individualized management with emphasis on education, empowerment, and use of advanced technologies. - See more at: http://madisonclinic.ucsf.edu/#sthash...

thm_03_03-2

糖尿病治療継続のために ~Patient・・・

視聴時間
0 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 5

糖尿病治療の国内外のエキスパートの先生方に、SGLT2阻害剤の魅力と、長期にわたる血糖低下効果が認められたフォシーガの臨床的価値について語っていただきました。


石井 均 先生 奈良県立医科大学 糖尿病学講座 教授


山﨑 真裕 先生 京都府立医科大学 内分泌・代謝内科学 学内講師


Serge Jabbour 先生 Thomas Jefferson University, USA


Stephan Jacob 先生 University of Tubingen,Germany

EASD Virtual Meeting

EASD Virtual Meeting

視聴時間1:06
0 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 5

Available on Android, iOS and PC and Mac. This free resource offers access to e-posters, webcasts, programme and programme planner and interactive community.

ACC 2015 Science in Context

ACC 2015 Science in ・・・

視聴時間9:42
0 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 5

Elliott Antman, MD, president of the American Heart Association, Mark Creager, MD, president-elect, and Bob Bonow, MD, past-president, discuss the potential impact of select science presented at the American College of Cardiology 2015 in San Diego, including PROMISE, PEGASUS, and upcoming PCSK9 research.

SWIFT PRIME: Potential New Emergency Therapy for Stroke

SWIFT PRIME: Potenti・・・

視聴時間4:16
0 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 5

Jeffrey L. Saver, MD, global principle investigator for SWIFT PRIME discusses the results of the study which he presented at the International Stroke Conference 2015 in Nashville. The trial was stopped early for efficacy and has the potential to provide new emergency therapy for patients with large vessel occlusion.

National Institute of Diabetes and Digestive and Kidney Diseases Interview – ENDO 2015

National Institute o・・・

視聴時間4:14
0 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 5

ENDO TV talks to Corinne M. Silva, PhD and Ronald Margolis, PhD of the National Institute of Diabetes and Digestive and Kidney Diseases about its key initiatives, its collaboration with the Endocrine Society, and the importance of attending the Meeting.

Endocrine Disruption: Proof, Costs, and Perspectives – ENDO 2015

Endocrine Disruption・・・

視聴時間4:18
0 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 5

It’s one of the hottest topics here at the 97th Annual Meeting and Expo – and ENDO TV had the opportunity to interview one of the speakers of the talk, "Endocrine Disruption: Proof, Costs, and Perspectives.” Leonardo Trasande, MD, MPP of the NYU School of Medicine gives us an overview of his talk.

CVD Epidemiology–Is There an App for That?

CVD Epidemiology--Is・・・

視聴時間9:08
0 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 5

Elliott Antman, MD, president of the American Heart Association, Mike Lauer, MD, Kevin Volpp, MD, PhD, and Lesley Curtiss, PhD, panelists for the opening session for Epidemiology and Prevention and Lifestyle and Cardiometabolic Health, 2015 discuss the potential impact of technology and big data on cardiovascular research and practice.

thm_04-3

Professor Stephan Ja・・・

視聴時間
0 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 5

世界で初めて発売されたSGLT2阻害剤のフォシーガについて、著名な先生方に、豊富な処方経験に基づくフォシーガの価値を語っていただきました​。

J-STARS–Statin Treatment for Recurrent Stroke Prevention

J-STARS--Statin Trea・・・

視聴時間8:43
0 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 50 votes, average: 0.00 out of 5

Bruce Ovbiagele, MD, program vice chair for the International Stroke Conference 2015, interviews Masayasu Matsamoto, MD, principle investigator for J-STARS about the results he presented during the meeting.